Connection

FIDA BACHA to Blood Glucose

This is a "connection" page, showing publications FIDA BACHA has written about Blood Glucose.
Connection Strength

3.656
  1. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.529
  2. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
    View in: PubMed
    Score: 0.477
  3. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr. 2013 May; 162(5):924-9.
    View in: PubMed
    Score: 0.301
  4. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
    View in: PubMed
    Score: 0.283
  5. Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity (Silver Spring). 2015 Jul; 23(7):1357-61.
    View in: PubMed
    Score: 0.178
  6. The association of self-reported sleep and circadian measures with glycemic control and diabetes complications among young adults with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2024 06 01; 326(6):H1386-H1395.
    View in: PubMed
    Score: 0.164
  7. Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
    View in: PubMed
    Score: 0.164
  8. ?-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.
    View in: PubMed
    Score: 0.128
  9. GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.127
  10. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
    View in: PubMed
    Score: 0.113
  11. Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors. J Diabetes Complications. 2018 Aug; 32(8):740-745.
    View in: PubMed
    Score: 0.109
  12. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes Care. 2016 Aug; 39(8):1431-9.
    View in: PubMed
    Score: 0.096
  13. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes. Pediatr Diabetes. 2016 12; 17(8):545-558.
    View in: PubMed
    Score: 0.092
  14. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016 09; 17(6):458-65.
    View in: PubMed
    Score: 0.090
  15. Progressive deterioration of ?-cell function in?obese youth with type 2 diabetes. Pediatr Diabetes. 2013 Mar; 14(2):106-11.
    View in: PubMed
    Score: 0.073
  16. One-hour plasma glucose concentration during the OGTT: what does it tell about ?-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes. 2011 Sep; 12(6):572-9.
    View in: PubMed
    Score: 0.067
  17. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
    View in: PubMed
    Score: 0.063
  18. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care. 2010 Mar; 33(3):632-8.
    View in: PubMed
    Score: 0.061
  19. Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring). 2006 Sep; 14(9):1579-85.
    View in: PubMed
    Score: 0.048
  20. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care. 2006 Jul; 29(7):1599-604.
    View in: PubMed
    Score: 0.048
  21. Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab. 2006 Aug; 91(8):3117-22.
    View in: PubMed
    Score: 0.048
  22. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017 08; 12(4):337-345.
    View in: PubMed
    Score: 0.047
  23. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015 Dec; 38(12):2285-92.
    View in: PubMed
    Score: 0.046
  24. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004 Feb; 27(2):547-52.
    View in: PubMed
    Score: 0.041
  25. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
    View in: PubMed
    Score: 0.028
  26. Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
    View in: PubMed
    Score: 0.027
  27. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
    View in: PubMed
    Score: 0.026
  28. Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017 Jan; 40(1):85-93.
    View in: PubMed
    Score: 0.025
  29. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 01; 314(21):2241-50.
    View in: PubMed
    Score: 0.023
  30. Metabolomic profiling of amino acids and ?-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
    View in: PubMed
    Score: 0.018
  31. HbA(1c) diagnostic categories and ?-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care. 2012 Dec; 35(12):2559-63.
    View in: PubMed
    Score: 0.018
  32. Declining ?-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care. 2011 Sep; 34(9):2033-40.
    View in: PubMed
    Score: 0.017
  33. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011 Jul; 96(7):2136-45.
    View in: PubMed
    Score: 0.017
  34. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009 Mar; 58(3):738-44.
    View in: PubMed
    Score: 0.014
  35. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care. 2008 Jul; 31(7):1445-7.
    View in: PubMed
    Score: 0.014
  36. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006 Feb; 148(2):188-94.
    View in: PubMed
    Score: 0.012
  37. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
    View in: PubMed
    Score: 0.012
  38. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. 2005 Mar; 28(3):638-44.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.